Skip to content
Screener

Twist Bioscience Corporation TWST Total costs & expenses

Total costs & expenses at other companies

Personalis, Inc. logo
Personalis, Inc.PSNL
$47.63M+24.4%
Maravai LifeSciences Holdings, Inc. logo
Maravai LifeSciences Holdings, Inc.MRVI
$35.74M-51.7%
Ginkgo Bioworks logo
Ginkgo BioworksDNA
$78.7M-19.1%
Zymeworks logo
ZymeworksZYME
$46.77M-5.3%
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
Agilent Technologies logo
Agilent TechnologiesA

Segments

By segment

See full
Reportable Segment$156.58M+16.5%

Other financials

Income statement

See full
Revenue$110.7M+19.3%
Gross profit$57.1M+24.1%
Operating income-$45.9M-10.4%
Net income-$44.0M-11.9%
EPS (diluted)-$0.71-7.6%

Balance sheet

See full
Cash & equivalents$124.9M-41.4%
Total debt$110.8M+16.3%
Total equity$455.1M+3.4%
Total assets$676.2M+13.5%

Cash flow

See full
Operating cash flow-$17.6M-35.2%
CapEx$7.9M+90.3%
Free cash flow-$25.4M-48.5%

Valuation

See full
Market cap$6.84B+338%
Enterprise value$6.83B+370%
P/S16.7×+12.4×

Profitability

See full
Gross margin52.1%+5.4pp
Operating margin-33.9%-9.9pp
Net margin-19.8%-7.7pp
FCF margin-23.2%+7.0pp

Returns & leverage

See full
Return on equity-18.2%-6.3pp
Debt / equity0.2×0.0×
Current ratio2.7×-1.8×

Where this comes from

Reported directly by Twist Bioscience Corporation in its filing.

Tagged under the XBRL concept us-gaap:CostsAndExpenses.

The source filing: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026.

Filed
May 4, 2026, 4:28 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q1 2026
Accession
0001581280-26-000040
(In thousands, except per share data)Three months ended March 31, 2026Three months ended March 31, 2025Six months ended March 31, 2026Six months ended March 31, 2025
Research and development expenses19,69523,91736,82545,224
Selling, general and administrative expenses[1]76,08563,671145,827119,849
Litigation settlement costs, net of recoveries7,2057,205
Total costs and expenses$156,578$134,353$293,176$257,711
Loss from operations$(45,863)$(41,560)$(78,763)$(76,205)
Interest income1,7102,8013,8856,041
Other income (expense), net[1]175(394)646(487)
Loss before income taxes$(43,978)$(39,153)$(74,232)$(70,651)

Item 1. Financial Statements (unaudited)

FAQ

What is Twist Bioscience Corporation's total costs & expenses?
Twist Bioscience Corporation (TWST) reported total costs & expenses of $156.58M in Q1 2026.
How has Twist Bioscience Corporation's total costs & expenses changed year-over-year?
Twist Bioscience Corporation's total costs & expenses increased by 16.5% year-over-year, from $134.35M to $156.58M.
What is the long-term trend for Twist Bioscience Corporation's total costs & expenses?
Over 4 years (2021 to 2025), Twist Bioscience Corporation's total costs & expenses has grown at a 15.8% compound annual growth rate (CAGR), from $285.06M to $512.83M.
What does total costs & expenses mean?
This metric aggregates all operating and non-operating costs incurred by the company to generate revenue, including cost of goods sold, research and development, and selling, general, and administrative expenses. It serves as a primary measure of the company's total burn rate and operational scale. Monitoring this figure is essential for assessing the company's path to profitability and cost management efficiency.

Ask your AI about Twist Bioscience Corporation's total costs & expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude